Earnings Call · Q3 FY2025·2025-10-30

Q3 25EPS +21.43%·Rev n/aQ2 25EPS +47.06%·Rev n/aQ1 25EPS +40.00%·Rev n/aQ4 24EPS -20.00%·Rev n/a⚠ consensus missing

Amneal Pharmaceuticals, Inc. AMRX

Anthony DiMeo — Head of Investor Relations

Chirag Patel — Chief Executive Officer

Chintu Patel — Chief Operating Officer

Anastasios Konidaris — Chief Financial Officer

−4.1%1d on move date−3.0% vs SPY3d+7.3%5d+12.1%

Research tier

Behavioral profile computed for 4 speakers on this call.

Sign in to view the Behavioral Lean, the Behavioral Deviation Score, the speaker decomposition, and the novel forward-guidance phrases flagged on this call — each scored against the speaker's own prior-call baseline.

Behavioral data on every earnings call

Per-speaker language deviation, scored against each executive's own history. Explore more AMRX calls or request research access.

More AMRX calls Browse calls Request research access